CDK4 and mantle cell lymphoma: Moreover, the inhibition of the CDK4/6-cyclin D1 complex activity, which in MCL cell lines is over-activated, with PD-0332991 [23], partly neutralized the cytotoxic effect of the Chk1 inhibitor.